1 people tracked
Investment thesis
The foundation advances its parent company's mission to deliver transformative therapies for glaucoma, corneal, and retinal diseases by providing the less fortunate with access to meaningful, safe, and long-term ophthalmic care. Operating through partnerships with over 158 humanitarian organizations, it has contributed more than 9,000 IOP-lowering products and stents to underserved glaucoma patients across 62 countries.
Source: firm website, verified Aug 5, 2026.
Team Β· 1 people
from public directories
What they invest in
from 3 of 4 portfolio companiesBiotech Γ3Medical Devices Γ3Digital Health Γ2Healthtech Γ1
Investments Β· 4 tracked
founders shown can be your intro pathCo-investorsAdvent Life Sciences
iDose TR (travoprost intracameral implant) is a procedural pharmaceutical implant that delivers continuous prostaglandin analog therapy into the anterior chamber to control intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
BiotechDigital HealthMedical Devices
iDose TR is a prescription travoprost intracameral implant and drug delivery system placed inside the eye to lower eye pressure in patients with open-angle glaucoma or ocular hypertension.
BiotechDigital HealthMedical Devices
Exits Β· 1
IPOs and acquisitions across the tracked portfolioGlaukosNYSE: GKOS
Frequently asked questions
- What sectors does Avedro, Inc. focus on?
- Avedro, Inc. focuses on Healthtech, Medical Devices.
Co-investors Β· 4
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
Wildcat Venture Partners is a venture capital firm that backs technology entrepreneurs aiming to create new market categories.
Johnson & Johnson Innovation is the innovation arm of Johnson & Johnson, working to advance life science innovation through early partnerships, incubation via JLABS, venture investing through JJDC, and late-stage partnerships to address global health challenges.
Domain Associates is a venture capital firm founded in 1985 that invests in life sciences companies. The firm operates as a limited liability company.
Firms observed investing alongside Avedro, Inc., from public investor directories. Shared companies are the overlap with Avedro, Inc.'s recorded portfolio.
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests β¬1 million to β¬15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.